4 ms·
It is a money issue - it is cheap and effective but needs clinical trials and potentially cuts recurring revenue from women's birth control options.
by eightysixfour 10y ago
It is a money issue - it is cheap and effective but needs clinical trials and potentially cuts recurring revenue from women's birth control options.
- cheez 10y agoAfter reading the article, I agree. The shaming is just how they're trying to get Big Pharma to take it up, but you cannot convince someone to reduce their salary willingly.